Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient models from Eli Lilly and Novo Nordisk.

Following in the footsteps of other pharmaceutical companies, Bristol Myers Squibb and Pfizer are offering Eliquis for cash-paying patients at a discount of 40% off the list price.

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

(Reuters) -Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, ...

A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly ...

But benzathine penicillin G is the only product that’s approved and recommended to treat the sexually transmitted infection syphilis during pregnancy. If the infection is caught early, a single ...